Denis Chem Lab Ltd

Wed 18/11/2026,16:1:0 | BSE : DENISCHEM

₹56.50-1.57 (-2.70%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 58.17

Previous Close

₹ 58.07

Volume

25512

Mkt Cap ( ₹ Cr)

₹ 78.40

High

₹ 60.99

Low

₹ 56.30

52 Week High

₹ 92.00

52 Week Low

₹ 54.50

Book Value Per Share

₹ 67.46

Dividend Yield

₹ 4.42

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Denis Chem Lab Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Denis Chem Lab Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Denis Chem Lab posts Q2 net loss of Rs 0.57 cr

    4 Nov 2026, 3:20PM The company reported standalone net loss during the quarter stood at Rs 0.57 crore compared to net profit of Rs 2.21 crore in the previous year quarte
  • Denis Chem Lab - Results - Unaudited Financial Results For The Quarter Ended 30Th September, 2026.

    4 Nov 2026, 3:07PM Unaudited Financial Results for the Quarter ended 30th September, 2026 along with Limited Review Report thereon.
  • Denis Chem Lab - Board Meeting Outcome for Outcome For Board Meeting - Submission Of Un-Audited Financial Results For The Qua

    4 Nov 2026, 2:58PM The Board of Directors in their meeting held today, have taken on record the Un-audited Financial Results for the Quarter ended on 30th September, 202
  • Denis Chem Lab - Board Meeting Intimation for Taking On Record Unaudited Financial Results For The Quarter Ended On 30Th Sept

    23 Oct 2026, 12:08PM Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and a
  • Denis Chem Lab has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    9 Oct 2026, 10:00PM As of September 2026, 38.98% is owned by Indian Promoters and 61.02% by Public. <p align=justify> Top three Promoters holding highest number of shares
  • Denis Chem Lab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Oct 2026, 11:57AM We are herewith submitting the Certificate issued by MUFG Intime India Private Limited, RTA of the Company for the Quarter ended on 30th September, 20
  • Denis Chem Lab - Announcement under Regulation 30 (LODR)-Change in Management

    25 Sep 2026, 4:19PM With reference to our earlier intimation vide letter dated 29th July, 2026, please note that in the Company's Annual General Meeting held today i.e. o
  • Denis Chem Lab - Announcement under Regulation 30 (LODR)-Change in Management

    25 Sep 2026, 4:00PM With reference to our earlier intimation vide letter dated 29th July, 2026, please note that in the Company's Annual General Meeting held today i.e. o
  • Denis Chem Lab - Intimation Of Approval Of Shareholders For Appointments Of Secretarial Auditors At 45Th AGM Of The Company.

    25 Sep 2026, 3:55PM With reference to our letter dated 29th July, 2026, this is to inform you that the Shareholders/ Members in their 45th Annual General Meeting (AGM) he
  • Denis Chem Lab - Shareholder Meeting / Postal Ballot-Outcome of AGM

    25 Sep 2026, 3:50PM Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer's Report.
  • Denis Chem Lab - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 3:48PM Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer's Report.
  • Denis Chem Lab - Shareholder Meeting / Postal Ballot-Outcome of AGM

    25 Sep 2026, 3:36PM We are enclosing herewith copy of the Proceedings of the 45th Annual General Meeting of the Company held on 25th September, 2026 through Video Confere
  • Denis Chem Lab - Proceedings Of 45Th Annual General Meeting

    25 Sep 2026, 3:29PM We are enclosing herewith copy of the Proceedings of the 45th Annual General Meeting of the Company held on 25th September, 2026 through Video Confer
  • Denis Chem Lab - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 3:48PM Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer's Report.
  • Denis Chem Lab - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 3:48PM Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer's Report.
  • Denis Chem Lab - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 3:48PM Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer's Report.
  • Denis Chem Lab - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 3:48PM Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer's Report.
  • Denis Chem Lab - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    25 Sep 2026, 3:48PM Declaration of Results of Resolutions passed at the 45th Annual General Meeting and Submission of Scrutineer's Report.
  • Denis Chem Lab has declared 25% Final dividend for the financial year March 2026

    23 Aug 2026, 6:20PM Denis Chem Lab Ltd. on Saturday, 30 May 2026, has announced Final dividend of 25 percent on Equity Share, to its shareholders holding shares on the re

Key fundamentals

Evaluate the intrinsic value of Denis Chem Lab Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 95.7578 85.9246 81.4125 74.1967 69.6689
Liabilities 95.7578 85.9246 81.4125 74.1967 69.6689
Equity 13.8767 13.8767 13.8767 13.8767 13.8767
Gross Profit 17.648 16.1083 21.2332 18.7799 14.3514
Net Profit 8.4093 8.0758 11.1558 7.8598 6.263
Cash From Operating Activities 4.1317 12.0919 17.6035 16.3396 17.0703
NPM(%) 4.62 4.66 6.64 4.88 4.58
Revenue 181.7204 173.2997 167.822 160.8489 136.5565
Expenses 164.0724 157.1914 146.5888 142.069 122.2051
ROE(%) 8.98 8.62 11.91 8.39 6.68

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Denis Chem Lab Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 751.60 -2.39 15.09 32.26 -26.19 0.66
Lotus Eye Hospital and Institute Ltd 102.45 -2.84 460.45 117.54 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 8.88 -1.44 0.00 244.05 -39.50 0.00
Astec Lifesciences Ltd 546.80 -2.05 0.00 125.94 -363.14 0.00

Company Info

The Company is Public Limited Pharmaceutical Company incorporated in 1982. Company started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years Company have been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. Company Manufacture and market sterile Intravenous injectibles in Both Glass and Plastic Bottles with capacity of 810 million bottles per Annum. 1980 -Incorporated as a Private Limited Company on July 15, 1980 1982 -Conversion into Public Limited Company -Initial Public Offer of our Company 1984 -Rights Issue of 70,000 equity shares at a issue price of ` 10/- per share 1989 -Rights Issue of 1,17,728 equity shares at a issue price of ` 10/- per share 1991 -Production capacity increased to 8 million glass bottles per annum 1994 -Production capacity again increased to 20 million glass bottles for I.V. Fluids 1995 -Further Public Offer of 1,80,750 equity shares 2006 -Company forayed into manufacturing of IV fluids in PP bottles using BFS technology 2013 -Issue of Bonus Shares in the ratio of 1:1 2014 -Listing of Equity Shares of our Company on BSE Limited under the Direct Listing Norms -Sucessfuly Launched Aqua Pulse Pan India -Company has issues Rights in the Ratio of 2 : 1 2018 -21,34,872 Equity Shares of Rs. 10/- each at a premium of Rs. 74/- per share on 'Rights Basis'

The Company is Public Limited Pharmaceutical Company incorporated in 1982. Company started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years Company have been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. Company Manufacture and market sterile Intravenous injectibles in Both Glass and Plastic Bottles with capacity of 810 million bottles per Annum. 1980 -Incorporated as a Private Limited Company on July 15, 1980 1982 -Conversion into Public Limited Company -Initial Public Offer of our Company 1984 -Rights Issue of 70,000 equity shares at a issue price of ` 10/- per share 1989 -Rights Issue of 1,17,728 equity shares at a issue price of ` 10/- per share 1991 -Production capacity increased to 8 million glass bottles per annum 1994 -Production capacity again increased to 20 million glass bottles for I.V. Fluids 1995 -Further Public Offer of 1,80,750 equity shares 2006 -Company forayed into manufacturing of IV fluids in PP bottles using BFS technology 2013 -Issue of Bonus Shares in the ratio of 1:1 2014 -Listing of Equity Shares of our Company on BSE Limited under the Direct Listing Norms -Sucessfuly Launched Aqua Pulse Pan India -Company has issues Rights in the Ratio of 2 : 1 2018 -21,34,872 Equity Shares of Rs. 10/- each at a premium of Rs. 74/- per share on 'Rights Basis'

Parent Organisation

Denis Chem Lab Ltd.

Founded

15/07/1980

Managing Director

Dr.Himanshu Patel

NSE Symbol

FAQ